Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $226
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group (NASDAQ:CME) and raises the price target from $225 to $226.
April 08, 2024 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on CME Group and raises the price target from $225 to $226.
The increase in price target by Barclays, even if minimal, signals a positive outlook on CME Group's stock by the analyst. This could lead to a short-term positive sentiment among investors, potentially pushing the stock price up.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100